sharecast

{{ storiesRelated.title }}

Full List Of Stories
20 Dec
Weekly review

London's FTSE 100 ended the week 229. 08 points higher at 7,582. 48.

20 Dec
tbc bank
FTSE 250 movers: TBC Bank falls, Hochschild shines

London's FTSE 250 was roughly flat, edging 0. 02% lower to 21,660. 78 in afternoon trade on Friday as TBC Bank led the fallers.

20 Dec
china usa
Europe midday: Markets rise on Sino-US optimism, German data in focus

European stocks were firmer at noon on Friday, as comments from US Treasury Secretary Steven Mnuchin ignited Sino-US trade hopes, while German consumer sentiment missed expectations.

20 Dec
oncology tumour pharma astrazeneca
Physiomics surges amid deepened Merck collaboration

Shares of Physiomics leapt on Friday after it signed up to a £250,000 tranche of projects with pharmaceutical giant Merck and said trading was in line with expectations.

20 Dec
Jaguar Land Rover, Range Rover Evoque, car manufacturing
Brexit-led factory shutdowns drive 16.5% slump in UK car production

Brexit-related factory closures led to a 16. 5% slump in November UK car production, according to figures released on Friday.

20 Dec
mnuchin
Europe open: Markets climb on trade deal hopes, German data eyed

European stocks rose on Friday morning, as comments from US Treasury Secretary Steven Mnuchin increased Sino-US trade optimism, while German consumer sentiment missed expectations.

20 Dec
Astrazeneca, pharmaceuticals, drugs, health, medical, tablets
AstraZeneca sells cancer drug duo rights to Juvisé

AstraZeneca on Friday said it had agreed to sell the commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) to Juvisé Pharmaceuticals in several European, African and other countries.